Successful treatment of long-standing neuro-Behçet's disease with infliximab.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15630746.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Behçet's disease is a chronic relapsing form of vasculitis affecting multiple organs. Central nervous system involvement is a common presentation. Tumor necrosis factor-alpha (TNF-alpha) is considered to play a major role in the disease pathogenesis. We describe a patient with a long history of neuro-Behçet's disease who showed a remarkable response to infliximab therapy. Given the variable and limited success of other interventions, the use of anti-TNF-alpha therapy seems to be effective for patients with refractory disease.
Medical subject headings
- Antibodies, Monoclonal
- Behcet Syndrome
- Central Nervous System Diseases
- Tumor Necrosis Factor-alpha